Alpha 2.0
Login Register
» Authors » Kelly Loggenberg

Kelly Loggenberg

Explore the profile of Kelly Loggenberg including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 190
Followers 0
Related Specialties
Oncology
Biochemistry
Gynecology & Obstetrics
Top 10 Co-Authors
Huw Dorkins
Jane Wardle
Ian Tomlinson
Sue Gessler
Ranjit Manchanda
Yvonne Wallis
Rakshit Desai
Chris Jacobs
Matthew Burnell
Usha Menon
Published In
J Natl Cancer Inst
Front Genet
J Med Genet
Mol Cytogenet
BJOG
Affiliations
Soon will be listed here.
Recent Articles
1.
Clinical outcomes of screen-positive genome-wide cfDNA cases for trisomy 20: results from the global expanded NIPT Consortium
Soster E, Mossfield T, Menezes M, Agenbag G, Dubois M, Gekas J, et al.
Mol Cytogenet . 2024 Apr; 17(1):9. PMID: 38627791
Trisomy 20 has been shown to be one of the most frequent rare autosomal trisomies in patients that undergo genome-wide noninvasive prenatal testing. Here, we describe the clinical outcomes of...
2.
Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes
Mossfield T, Soster E, Menezes M, Agenbag G, Dubois M, Gekas J, et al.
Front Genet . 2022 Sep; 13:975987. PMID: 36105088
Cell-free (cf) DNA screening is a noninvasive prenatal screening approach that is typically used to screen for common fetal trisomies, with optional screening for sex chromosomal aneuploidies and fetal sex....
3.
Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term secondary lifestyle behavioural outcomes
Burnell M, Gaba F, Sobocan M, Desai R, Sanderson S, Loggenberg K, et al.
BJOG . 2022 Jul; 129(12):1970-1980. PMID: 35781768
Objective: Ashkenazi-Jewish (AJ) population-based BRCA testing is acceptable, cost-effective and amplifies primary prevention for breast & ovarian cancer. However, data describing lifestyle impact are lacking. We report long-term results of...
4.
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations
Manchanda R, Burnell M, Loggenberg K, Desai R, Wardle J, Sanderson S, et al.
J Med Genet . 2016 Mar; 53(7):472-80. PMID: 26993268
Background: Newer approaches to genetic counselling are required for population-based testing. We compare traditional face-to-face genetic counselling with a DVD-assisted approach for population-based BRCA1/2 testing. Methods: A cluster-randomised non-inferiority trial...
5.
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing
Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, et al.
J Natl Cancer Inst . 2014 Dec; 107(1):380. PMID: 25435542
Background: Population-based testing for BRCA1/2 mutations detects the high proportion of carriers not identified by cancer family history (FH)-based testing. We compared the cost-effectiveness of population-based BRCA testing with the...
6.
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial
Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S, et al.
J Natl Cancer Inst . 2014 Dec; 107(1):379. PMID: 25435541
Background: Technological advances raise the possibility of systematic population-based genetic testing for cancer-predisposing mutations, but it is uncertain whether benefits outweigh disadvantages. We directly compared the psychological/quality-of-life consequences of such...